SCHEMBL29566655

SCHEMBL29566655

CC1(C)CC=C(c2cc(Oc3ccccc3)nc(NS(=O)(=O)c3ccccc3)n2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ GPR39 O43194 1/20 0.39
▸ MAPT P10636 2/20 0.38
▸ PGR P06401 4/20 0.38
▸ GAA P10253 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ PIK3CD O00329 1/20 0.36
▸ PIK3R1 P27986 1/20 0.36
▸ PIK3CA P42336 1/20 0.36
▸ PIK3CB P42338 1/20 0.36
▸ PIK3CG P48736 1/20 0.36
▸ CYP1A2 P05177 2/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309909 1.00 TSHR (0.44) TSHRSMN1; SMN2GPR39MAPTPGR
SCHEMBL24309912 0.82 GPR39 (0.40) GPR39MAPTALDH1A1KDM4ELMNA
SCHEMBL26811043 0.81 TSHR (0.45) TSHRSMN1; SMN2GPR39MAPTPGR
SCHEMBL26810818 0.81 PIK3CD (0.50) TSHRSMN1; SMN2GPR39MAPTPGR
SCHEMBL26811018 0.80 TSHR (0.44) TSHRSMN1; SMN2GPR39MAPTPGR
SCHEMBL26811014 0.80 SMN1; SMN2 (0.44) TSHRSMN1; SMN2GPR39MAPTPGR
SCHEMBL24309305 0.79 HTR1A (0.35) TSHRSMN1; SMN2GPR39MAPTALDH1A1
SCHEMBL29566709 0.79 HTR1A (0.35) TSHRSMN1; SMN2GPR39MAPTALDH1A1
SCHEMBL24310495 0.78 TSHR (0.44) TSHRSMN1; SMN2GPR39MAPTPGR
SCHEMBL29566660 0.78 TSHR (0.44) TSHRSMN1; SMN2GPR39MAPTPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback